1
/
의
1
AntibodySystem
SKU(재고 관리 코드):DHJ41099
Enfortumab vedotin-ejfv (ADC)
Enfortumab vedotin-ejfv (ADC)
Catalog No.: DHJ41099
| Catalog No. | DHJ41099 |
|---|---|
| Product name | Enfortumab vedotin-ejfv (ADC) |
| Size | 5 mg |
| Species reactivity | Human |
| Applications | Research Grade Biosimilar |
| Description | Enfortumab vedotin-ejfv is an ADC consisting of a Nectin-4-directed antibody and Monomethyl auristatin E (MMAE) , suitable for adult patients with locally advanced or metastatic urothelial carcinoma, or who have received programmed cell death protein 1 (PD-1) inhibitor or programmed cell death ligand 1 (PD-L1) inhibitor therapy or neoadjuvant/adjuvant platinum-based chemotherapy for locally advanced or metastatic cancer. |
| Form | Liquid |
| Purity | >90% as determined by SEC. |
| Clonality | Monoclonal |
| Target | LNIR, NECTIN4, PRR4 receptor-related protein 4, Nectin cell adhesion molecule 4, Ig superfamily receptor LNIR, Nectin-4, PVRL4 |
| Purification | Purified by Ion Exchange Chromatography. |
| Endotoxin level | Please contact with the lab for this information. |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term. |
| Alternative Names | Padcev, ASG-22ME |
| Clone ID | Enfortumab vedotin-ejfv |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Share
